Stuart Levitz to Antibodies, Monoclonal
This is a "connection" page, showing publications Stuart Levitz has written about Antibodies, Monoclonal.
Connection Strength
0.107
-
Levitz SM, Tabuni A, Kozel TR, MacGill RS, Ingalls RR, Golenbock DT. Binding of Cryptococcus neoformans to heterologously expressed human complement receptors. Infect Immun. 1997 Mar; 65(3):931-5.
Score: 0.025
-
Levitz SM, North EA, Dupont MP, Harrison TS. Mechanisms of inhibition of Cryptococcus neoformans by human lymphocytes. Infect Immun. 1995 Sep; 63(9):3550-4.
Score: 0.023
-
Roseff SA, Levitz SM. Effect of endothelial cells on phagocyte-mediated anticryptococcal activity. Infect Immun. 1993 Sep; 61(9):3818-24.
Score: 0.020
-
Jesus MD, Nicola AM, Chow SK, Lee IR, Nong S, Specht CA, Levitz SM, Casadevall A. Glucuronoxylomannan, galactoxylomannan, and mannoprotein occupy spatially separate and discrete regions in the capsule of Cryptococcus neoformans. Virulence. 2010 Nov-Dec; 1(6):500-8.
Score: 0.016
-
Levitz SM, DiBenedetto DJ. Paradoxical role of capsule in murine bronchoalveolar macrophage-mediated killing of Cryptococcus neoformans. J Immunol. 1989 Jan 15; 142(2):659-65.
Score: 0.014
-
Kozel TR, Levitz SM, Dromer F, Gates MA, Thorkildson P, Janbon G. Antigenic and biological characteristics of mutant strains of Cryptococcus neoformans lacking capsular O acetylation or xylosyl side chains. Infect Immun. 2003 May; 71(5):2868-75.
Score: 0.010